Literature DB >> 18767893

NICE Methodology for Technology Appraisals: cutting edge or tried and trusted?

Louise Longworth, Carole Longson.   

Abstract

Mesh：

Year:  2008        PMID： 18767893     DOI： 10.2165/00019053-200826090-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  8 in total

1.  Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance.

Authors:  David Barnett; Seren Phillips; Carole Longson
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

2.  Estimating 'costs' for cost-effectiveness analysis.

Authors:  Alec Miners
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 3.  The NICE cost-effectiveness threshold: what it is and what that means.

Authors:  Christopher McCabe; Karl Claxton; Anthony J Culyer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 4.  Use of indirect and mixed treatment comparisons for technology assessment.

Authors:  Alex Sutton; A E Ades; Nicola Cooper; Keith Abrams
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Exploring uncertainty in cost-effectiveness analysis.

Authors:  Karl Claxton
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 6.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 7.  The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Authors:  R Garside; M Pitt; R Anderson; G Rogers; M Dyer; S Mealing; M Somerville; A Price; K Stein
Journal:  Health Technol Assess       Date:  2007-11       Impact factor: 4.014

8.  Subgroups and heterogeneity in cost-effectiveness analysis.

Authors:  Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981
  8 in total
  4 in total

1.  NICE's 2008 Methods Guide: sensible consolidation or opportunities missed?

Authors:  Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 2.  A review of generic preference-based measures of health-related quality of life in visual disorders.

Authors:  Jonathan Tosh; John Brazier; Philippa Evans; Louise Longworth
Journal:  Value Health       Date:  2011-10-01       Impact factor: 5.725

3.  Justice, Transparency and the Guiding Principles of the UK's National Institute for Health and Care Excellence.

Authors:  Victoria Charlton
Journal:  Health Care Anal       Date:  2021-11-08

4.  Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial.

Authors:  Habib Rehman Khan; Ines Kralj-Hans; Shouvik Haldar; Toufan Bahrami; Jonathan Clague; Anthony De Souza; Darrel Francis; Wajid Hussain; Julian Jarman; David Gareth Jones; Neeraj Mediratta; Raad Mohiaddin; Tushar Salukhe; Simon Jones; Joanne Lord; Caroline Murphy; Joanna Kelly; Vias Markides; Dhiraj Gupta; Tom Wong
Journal:  Trials       Date:  2018-02-20       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.